Antithrombotic Therapy for Chronic Kidney Disease Patients With Concomitant Atrial Fibrillation and Coronary Artery Disease

Antithrombotic Therapy for Chronic Kidney Disease Patients With Concomitant Atrial Fibrillation and Coronary Artery Disease

Background: Oral anticoagulants (OAC) plus antiplatelets is recommended for patients with atrial fibrillation (AF) and coronary artery disease (CAD) to reduce thromboembolism. However, there is limited evidence regarding antithrombotic therapy for patients with concomitant chronic kidney disease (CK...

Full description

Bibliographic Details
Main Authors: Kuo-Hua Lee, Shuo-Ming Ou, Yuan-Chia Chu, Yao-Ping Lin, Ming-Tsun Tsai, Der-Cherng Tarng
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-10-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
anticoagulation
acute myocardial infarction
atrial fibrillation
stroke
thromboembolism
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2021.751359/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2021.751359/full

Similar Items